MAP1LC3A antibody (N-Term)
Quick Overview for MAP1LC3A antibody (N-Term) (ABIN363515)
Target
See all MAP1LC3A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-100, N-Term
-
Specificity
- Reacts withLC3 from human, mouse, rat, bacteria, golden syrian hamster, porcine and zebrafish
-
Purification
- Antigen affinity purified
-
Immunogen
- Synthetic peptide made to an N-terminal portion of the human LC3 protein sequence (between residues 1-100)
-
-
-
-
Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
WB0.5-2 μg/mL ICC/IF1:200 IHC1:200-1:400 IP20 μg/500 μg of protein -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Tris-glycine, 150 mM NaCl, Sodium azide 0.05 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C/-80 °C
-
Storage Comment
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
-
Alternative Name
- Light Chain 3 (LC3)
-
Background
- Ubiquitin-like modifier involved in formation of autophagosomal vacuoles (autophagosomes). Plays a role in mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. Whereas LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation. Promotes primary ciliogenesis by removing OFD1 from centriolar satellites via the autophagic pathway.
-
Gene ID
- 81631
-
Pathways
- Autophagy
Target
-